Juliana M McElrath
Overview
Explore the profile of Juliana M McElrath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
5437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
deCamp A, Corcoran M, Fulp W, Willis J, Cottrell C, Bader D, et al.
NPJ Vaccines
. 2024 Mar;
9(1):58.
PMID: 38467663
Vaccine priming immunogens that activate germline precursors for broadly neutralizing antibodies (bnAbs) have promise for development of precision vaccines against major human pathogens. In a clinical trial of the eOD-GT8...
2.
deCamp A, Corcoran M, Fulp W, Willis J, Cottrell C, Bader D, et al.
medRxiv
. 2023 Mar;
PMID: 36993183
One-sentence Summary: Human genetic variation can modulate the strength of vaccine-induced broadly neutralizing antibody precursor B cell responses.
3.
Campion S, Brenna E, Thomson E, Fischer W, Ladell K, McLaren J, et al.
J Clin Invest
. 2021 Dec;
131(23).
PMID: 34850742
Naive and memory CD4+ T cells reactive with human immunodeficiency virus type 1 (HIV-1) are detectable in unexposed, unimmunized individuals. The contribution of preexisting CD4+ T cells to a primary...
4.
Hao Y, Hao S, Andersen-Nissen E, Mauck 3rd W, Zheng S, Butler A, et al.
Cell
. 2021 Jun;
184(13):3573-3587.e29.
PMID: 34062119
The simultaneous measurement of multiple modalities represents an exciting frontier for single-cell genomics and necessitates computational methods that can define cellular states based on multimodal data. Here, we introduce "weighted-nearest...
5.
Astronomo R, Santra S, Ballweber-Fleming L, Westerberg K, Mach L, Hensley-McBain T, et al.
EBioMedicine
. 2016 Dec;
14:97-111.
PMID: 27919754
HIV-1 infection occurs primarily through mucosal transmission. Application of biologically relevant mucosal models can advance understanding of the functional properties of antibodies that mediate HIV protection, thereby guiding antibody-based vaccine...
6.
Park H, Adamson L, Ha T, Mullen K, Hagen S, Nogueron A, et al.
J Immunol
. 2013 Mar;
190(8):4103-15.
PMID: 23509365
Prime-boost immunization with heterologous vaccines elicits potent cellular immunity. In this study, we assessed the influence of various TLR ligands on SIV Gag-specific T cell immunity and protection following prime-boost...
7.
Li F, McKenney D, Malhotra U, Crimi C, Nolin J, Corey L, et al.
Hum Vaccin
. 2008 Apr;
4(2):115-21.
PMID: 18382130
The cellular immune system is characterized by flexibility with respect to epitope recognition at the level of peptide binding to HLA molecules and HLA-peptide complexes to T-cell receptors (TCRs). For...
8.
Li F, Horton H, B Gilbert P, McElrath J, Corey L, Self S
Curr HIV Res
. 2007 Feb;
5(1):97-107.
PMID: 17266561
Much of the current effort in HIV-1 vaccine design is directed at achieving T-cell immunity that will result in enough immunological memory to contain HIV-1 infection after acquisition. However, antigenic...
9.
Li F, Malhotra U, B Gilbert P, Hawkins N, Duerr A, McElrath J, et al.
Vaccine
. 2006 Aug;
24(47-48):6893-904.
PMID: 16890329
Dozens of human immunodeficiency virus-type 1 (HIV-1) vaccine candidates specifically designed to elicit cytotoxic T-lymphocyte (CTL) responses have entered the pipeline of clinical trials. Evaluating the immunogenicity and potential efficacy...